LU-177-SSTR- PNT-2003

N/A

Report date: 2025/11/25 15:53:14

Base Information

Drug NameLU-177-SSTR- PNT-2003
Drug Alias NameLU-177-PNT-2003PNT-2003
ClassificationRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Radioactive therapeutic agent
Mechanisms of ActionIonising radiation emittersSomatostatin receptor binders
TargetsSomatostatin receptor
Therapy Area/IndicationsNeuroendocrine Tumors
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesPoint Biopharma Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeuroendocrine Tumors
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A